Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
National Health InvestorsFRA:WX6 -0.81%79 EV-to-EBIT is 21.38 as of Sep. 05, 2026, which is 5% below its 10-year median of 22.47. GuruFocus rates FRA:WX6 with a GF Score™ of 79/100 and a GF Value™ of €72.91 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 647 REITs companies, National Health Investors ranks worse than 58.58% on this metric.
National Health Investors (FRA:WX6) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
National Health Investors's Enterprise Value for the quarter that ended in Jun. 2026 was €4,389.4 Mil.
National Health Investors's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €190.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Health Investors EV-to-EBIT Related Terms
National Health Investors EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the REIT - Healthcare Facilities subindustry, National Health Investors's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
National Health Investors EV-to-EBIT vs REITs Industry
For the REITs industry and Real Estate sector, National Health Investors's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where National Health Investors's EV-to-EBIT falls into.
National Health Investors's current Enterprise Value is €4,082.2 Mil.
National Health Investors's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €190.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Health Investors (FRA:WX6) has a EV-to-EBIT of 21.38 as of Sep. 05, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on National Health Investors and its competitors. This is near median its historical median of 22.47. Over the past decade, National Health Investors' EV-to-EBIT has ranged from 13.34 to 37.22. According to the industry distribution chart, National Health Investors ranks #379 out of 647 companies in the REITs industry, placing it in the top 58.6%.
Is National Health Investors' EV-to-EBIT too high?
National Health Investors' current EV-to-EBIT of 21.38 is near median its 10-year median of 22.47. Over the past 10 years, this metric has ranged from a low of 13.34 to a high of 37.22. The REITs industry median EV-to-EBIT is 17.56. National Health Investors' value of 21.38 is 21.8% above this industry median. Based on the distribution chart, National Health Investors ranks #379 out of 647 companies in the REITs industry, which is below the industry midpoint. Overall, National Health Investors has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does National Health Investors' EV-to-EBIT compare to MPT and LTC?
According to the REITs industry distribution chart, National Health Investors ranks #379 out of 647 companies for EV-to-EBIT. This places National Health Investors in the lower half of its industry. The industry median EV-to-EBIT is 17.56. National Health Investors' value of 21.38 is 21.8% above this benchmark. Historically, National Health Investors' own EV-to-EBIT has ranged from 13.34 to 37.22 over the past decade. While the company's 10-year median is 22.47 vs. the industry median of 17.56, National Health Investors has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a REITs company?
The median EV-to-EBIT among REITs companies is 17.56, based on 647 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. National Health Investors's current EV-to-EBIT of 21.38 is 21.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on National Health Investors and its competitors. For the REITs industry, the median EV-to-EBIT is 17.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. National Health Investors's current EV-to-EBIT is 21.38, which is near median its own 10-year median of 22.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Health Investors stock overvalued right now?
Based on GuruFocus' analysis, National Health Investors (FRA:WX6) is currently considered Modestly Undervalued. The stock's GF Value™ is €72.91, compared to a current price of €61.00 — trading 16.3% below its estimated fair value. The current EV-to-EBIT is 21.38, which is near median its 10-year median of 22.47 and 21.8% above the REITs industry median of 17.56. National Health Investors' overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For National Health Investors (FRA:WX6), the current EV-to-EBIT is 21.38 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is National Health Investors (FRA:WX6) Overvalued in 2026?
Based on GuruFocus' analysis, National Health Investors stock appears to be undervalued.
The current stock price of €61.00 is trading 16.3% below its estimated GF Value™ of €72.91.
GuruFocus considers National Health Investors to be Modestly Undervalued.
Key valuation signals for FRA:WX6:
EV-to-EBIT: 21.38 (near median its 10-year median of 22.47)
GF Value™: €72.91 vs. price of €61.00 (16.3% below fair value)
Industry Position: 21.8% above the REITs median (#379 of 647)
No single metric tells the full story. See the FRA:WX6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.
79GF Score
Get the complete analysis for FRA:WX6
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:WX6 has been successfully added to your 
